Skip to main content

Table 3 ucRNA expression changes in LNCaP cells after treatment with R1881

From: Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer

ucRNA Fold Change* FDR (%) P value Type‡, host gene, host strand Overlap with mRNA Antisense to mRNA
uc.287+ 1.83 7.8 0.034 p, no gene Yes  
uc.445 + A 1.44 28.8 0.042 n, no gene No  
uc.134+ 1.39 28.8 0.029 n, RSRC1 Yes  
uc.240+ 1.37 28.8 0.019 n, no gene Yes Yes
uc.249 + A 0.80 13.7 0.026 n, no gene No  
uc.349+ 0.78 13.1 0.021 n, DACH1, antisense Yes Yes
uc.204+ 0.76 9.7 0.025 n, no gene No  
uc.135+ 0.65 1.6 0.01 e, MECOM, antisense Yes Yes
uc.31+ 0.61 1.6 0.025 p, no gene Yes  
uc.410 + A 0.58 0.0 0.022 n, no gene No  
uc.344+ 0.57 0.0 0.037 e, HOXC5, sense Yes Yes
uc.283 + A 0.52 0.0 0.032 n, no gene No  
uc.283+ 0.26 0.0 0.008 n, no gene No  
  1. * Fold change: reference are the untreated cells (solvent only); †Cutoff for inclusion: P value (t-test) < 0.05 for all ucRNAs; ‡ Type is based on UCSC human genome data, UCSC version hg19, NCBI build 37 coordinates, where n = nonexonic, e = exonic, and p = possibly exonic.